YOLFTbeta
Futura Medical

Futura Medical

FUM · LSE · Healthcare / Biotechnology

0.259GBX-0.02 (-7.50%)

Price History

Full chart

Market Stats

Previous Close0.28
Open0.26
Day Range0.2315 – 0.2879
52-Week Range0.18 – 3.35
Volume6.56M
Market Cap3.26M
P/E (TTM)0.00
Forward P/E12.50
EPS-0.01
Dividend Yield0.00%
Beta-0.00
50-Day Avg0.3183
200-Day Avg0.8022

About

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Alexander James Hanbury Duggan
  • Employees13
  • HeadquartersSurrey Technology Centre, Guildford, United Kingdom, GU2 7YG, UK
  • Websitehttps://www.futuramedical.com

Leadership

  • Mr. Alexander James Hanbury DugganCEO & Executive Director · b. 1970
  • Ms. Angela HildrethCOO, Finance Director, Company Secretary & Executive Director · b. 1980
  • Mr. Kenneth William JamesHead of R&D & Executive Director · b. 1952
  • Dr. William Duncan Potter BSc (Hons), MSc, Ph.D.Chief Scientific Officer & Adviser to the Board · b. 1948
  • Mr. Kevin LangridgeHead of Quality

Financials

Income Statement

Currency: GBP2001-01-312002-01-312003-01-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----130.00K2.00K-15.00K150.00K50.00K125.00K158.00K75.00K370.90K43.93K29.48K170.36K362.73K031.78K0003.10M13.93M1.70M
Growth (%)------98.46%--+900.00%-66.67%+150.00%+26.40%-52.53%+394.54%-88.16%-32.90%+477.97%+112.92%-100.00%--100.00%---+349.09%-87.82%
Cost of Revenue-652.00K-518.00K---------0000019.85K-25.01K19.81K24.73K1.33M4.24M456.71K
Gross Profit----130.00K2.00K-15.00K150.00K50.00K125.00K158.00K75.00K370.90K43.93K29.48K170.36K362.73K-19.85K31.78K-25.01K-19.81K-24.73K1.77M9.57M1.24M
Gross Margin----100.00%100.00%-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-100.00%---57.22%68.70%73.08%
Operating Expense----1.71M2.36M-2.64M2.33M1.58M1.46M2.26M2.53M2.90M3.57M6.15M4.72M5.22M7.25M11.20M2.90M5.85M6.85M8.74M8.39M6.90M
Operating Income-392.00K-1.34M-1.30M-1.51M-1.58M-2.36M-2.11M-2.62M-2.17M-1.53M-1.34M-2.10M-2.46M-2.53M-3.53M-6.12M-4.55M-4.86M-7.27M-11.16M-2.93M-5.87M-6.87M-6.96M1.18M-5.66M
Operating Margin-----1212.31%-117800.00%--17493.33%-1450.00%-3052.00%-1068.80%-1328.48%-3274.57%-682.54%-8028.47%-20751.81%-2673.17%-1338.73%--35130.49%----224.57%8.44%-333.48%
EBITDA-385.00K-1.31M-1.22M-1.45M-1.56M-2.34M-1.96M-2.61M-2.16M-1.52M-1.33M-2.09M-2.45M-2.53M-3.52M-6.11M-4.55M-4.84M-7.22M-11.14M-2.90M-5.85M-6.85M-6.83M1.41M-5.54M
EBITDA Margin-----1203.85%-117200.00%--17373.33%-1438.67%-3034.00%-1063.20%-1325.94%-3271.66%-681.52%-8018.17%-20728.20%-2669.51%-1335.03%--35065.34%----220.37%10.14%-326.29%
Net Income-372.00K-1.25M-1.08M-1.36M-1.23M-1.94M-1.78M-2.25M-1.94M-1.39M-1.09M-1.81M-2.18M-2.21M-3.00M-5.08M-3.70M-3.90M-5.88M-8.92M-2.41M-4.96M-5.85M-6.51M1.29M-9.07M
Net Income Margin-----945.38%-96800.00%--15026.67%-1290.00%-2786.00%-872.80%-1148.73%-2902.20%-595.40%-6824.38%-17239.25%-2170.15%-1075.27%--28067.50%----210.03%9.28%-534.62%
R&D207.00K683.00K811.00K627.00K960.00K1.55M1.08M1.52M1.40M810.00K762.00K1.00K1.44M1.98M2.37M4.78M3.51M4.10M6.04M10.05M1.93M3.77M4.13M2.05M1.74M1.61M
R&D as % of Total Revenue----738.46%77650.00%-10133.33%932.00%1620.00%609.60%0.63%1914.31%532.84%5385.23%16209.93%2060.13%1130.45%-31629.27%---65.98%12.51%95.07%
Interest Expense16.00K29.00K1.00K1.00K185.00K134.00K136.00K158.00K96.00K16.00K19.00K24.00K18.49K9.53K48.26K38.33K14.71K19.32K27.58K22.28K9240----
Interest Expense % of Total Revenue----142.31%6700.00%-1053.33%64.00%32.00%15.20%15.19%24.65%2.57%109.85%130.02%8.64%5.33%-70.12%------

Balance Sheet

Currency: GBP2001-01-312002-01-312003-01-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets336.00K2.26M1.77M2.59M3.97M2.22M4.18M3.09M1.04M2.08M1.05M2.95M3.21M1.47M10.33M5.52M13.44M9.60M10.88M4.90M1.62M11.80M6.47M11.82M13.59M5.22M
Total Liabilities630.00K262.00K247.00K180.00K225.00K237.00K236.00K315.00K152.00K224.00K152.00K194.00K334.95K478.00K607.89K729.12K855.18K499.14K2.03M4.85M766.52K2.08M1.75M6.34M4.63M2.41M
Total Equity-294.00K2.00M1.52M2.41M3.75M1.98M3.95M2.77M886.00K1.85M901.00K2.76M2.87M987.77K9.72M4.79M12.58M9.11M8.85M53.65K853.54K9.72M4.72M5.48M8.96M2.81M
Cash290.00K2.04M1.51M2.40M3.67M1.81M2.74M2.64M782.00K1.79M825.00K2.58M2.82M990.57K9.49M4.19M12.35M8.36M9.16M2.51M1.02M10.37M4.03M7.71M6.60M3.40M
Total Debt527.00K-------------------------
Net Debt237.00K-2.04M-1.51M-2.40M-3.67M-1.81M-2.74M-2.64M-782.00K-1.79M-825.00K-2.58M-2.82M-990.57K-9.49M-4.19M-12.35M-8.36M-9.16M-2.51M-1.02M-10.37M-4.03M-7.71M-6.60M-3.40M

Cash Flow

Currency: GBP2001-01-312002-01-312003-01-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-316.00K-1.28M-1.06M-1.36M-1.45M-2.13M-1.85M-2.28M-1.97M-1.32M-1.05M-1.84M-1.94M-2.01M-3.07M-5.36M-3.30M-4.17M-4.71M-6.66M-4.54M-3.87M-5.78M570.25K438.41K-5.62M
Investing Cash Flow-2.00K-2.04M480.00K-843.00K-1.01M1.91M-919.00K1.16M115.00K10.00K16.00K25.00K11.96K6.17K13.06K35.62K22.17K-36.28K23.07K-10.45K-7.45K-419.72K-740.70K-1.43M-1.73M38.19K
Financing Cash Flow600.00K3.09M534.00K2.25M2.57M136.00K3.70M1.01M-2.31M67.00K3.57M2.16M181.33K11.55M24.75K11.44M220.75K5.48M19.28K3.06M13.65M169.58K4.55M170.91K2.38M
Capital Expenditure2.00K50.00K3.00K2.00K21.00K14.00K5.00K31.00K2.00K1.00K6.00K04.25K5.05K7.79K15.96K7.48K55.59K4.51K32.74K8.37K419.72K740.70K1.51M1.73M3
Free Cash Flow-318.00K-1.33M-1.06M-1.36M-1.47M-2.14M-1.86M-2.31M-1.97M-1.32M-1.05M-1.84M-1.95M-2.02M-3.07M-5.38M-3.31M-4.23M-4.71M-6.69M-4.55M-4.29M-6.52M-935.60K-1.29M-5.58M
FCF to OCF100.63%103.89%100.28%100.15%101.45%100.66%100.27%101.36%100.10%100.08%100.57%100.00%100.22%100.25%100.25%100.30%100.23%101.33%100.10%100.49%100.18%110.84%112.83%-164.07%-293.91%99.32%

Earnings

Report DateMar 28, 2014Sep 15, 2014Apr 21, 2016Sep 13, 2016Mar 23, 2017Sep 12, 2017Mar 21, 2018Sep 26, 2018Apr 10, 2019Sep 11, 2019Apr 1, 2020Sep 16, 2020Mar 29, 2021Sep 29, 2021Apr 26, 2022Sep 13, 2022Apr 5, 2023Apr 15, 2025Sep 30, 2025
EPS Estimate0.000.00-1.590.000.000.000.000.000.000.000.000.000.00---0.000.000.00
EPS Actual0.000.00-0.03-0.02-0.02-0.01-0.02-0.02-0.03-0.02-0.020.00-0.01-0.01-0.01-0.010.000.00-0.02
Surprise--98.11%----------------
Timing--------------Pre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap3.26M
Enterprise Value34.76K
Trailing P/E0.00
Forward P/E12.50
PEG Ratio0.00
Price / Sales1.41
Price / Book0.64
EPS-0.01
Book Value0.003
Revenue (TTM)2.32M
Gross Profit (TTM)2.62M
EBITDA-2.98M
Profit Margin-158.22%
Operating Margin-73.78%
Return on Equity-145.13%
Return on Assets-40.08%
Shares Outstanding1.48B
Shares Float510.43M
Beta-0.00
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 22, 2018703:699